DIABETIC RETINOPATHY MARKET ANALYSIS

Diabetic Retinopathy Market, By Disease Type (Proliferative Diabetic Retinopathy and Non-proliferative Diabetic Retinopathy), By Treatment Type (Anti-Vascular Endothelial Growth Factor Therapy, Intraocular Steroid Injection, Laser Surgery, Vitrectomy, and Others), By Route of Administration (Intravitreal Injections, Intravitreal Implants, Oral, Topical Eye Drops, Laser Surgery, and Others), By End User (Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers, Long-Term Care Centers, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Feb 2025
Code : CMI3313
Pages :140
Formats :
Excel and PDF
Industry : Pharmaceutical

Diabetic Retinopathy Market Size and Trends

The global diabetic retinopathy market is estimated to be valued at USD 9.91 Bn in 2025 and is expected to reach USD 15.40 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.

Diabetic Retinopathy Market Key Factors

To learn more about this report, Request sample copy

The growing prevalence of diabetes worldwide is expected to drive the growth of the diabetic retinopathy market during the forecast period. In November 2021, as per the International Diabetes Federation, approximately 537 million adults aged 20-79 years were living with diabetes in 2021 worldwide, and by 2030, this number is projected to rise to 643 million. Diabetic retinopathy, which is a common complication of diabetes, can potentially lead to blindness if not detected and treated promptly. With rising diabetes population, the prevalence of diabetic retinopathy is also expected to increase substantially in the coming years.

DIABETIC RETINOPATHY MARKET ANALYSIS

Diabetic Retinopathy Market Size and Trends

Diabetic Retinopathy Market Report Snapshots

EXISTING CLIENTELE